TB Alliance
![](https://niroglobal.com/wp-content/uploads/2023/04/Organization-Chart-2.png)
![](https://niroglobal.com/wp-content/uploads/2023/04/Goal.png)
TB Alliance is a not-for-profit product development partnership (PDP) dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs. It holds the largest pipeline of new TB drugs in history and has advanced multiple products to market.
![](https://niroglobal.com/wp-content/uploads/2023/04/Upward-2.png)
TB Alliance does not provide grants or awards to academic researchers or to any other party engaged in tuberculosis research, but enters into research and development collaborations around a particular drug discovery or drug development program.
For more information about partnership opportunities, please contact Gerald Siuta.
![](https://niroglobal.com/wp-content/uploads/2023/04/Bull-Horn.png)
N/A
![](https://niroglobal.com/wp-content/uploads/2023/04/Time-Table.png)
N/A
![](https://niroglobal.com/wp-content/uploads/2023/04/Cycle-1.png)
N/A
![](https://niroglobal.com/wp-content/uploads/2023/04/Life-Sciences.png)
Partnership
![](https://niroglobal.com/wp-content/uploads/2023/04/Health-Check.png)
Potential partners can be an academic or government organisation, a biotech or pharmaceutical company or another product development partnership.
Preferred attributes of potential anti-TB drugs are listed here.
![](https://niroglobal.com/wp-content/uploads/2023/04/Executive-Board-Advisory.png)
Unknown
![](https://niroglobal.com/wp-content/uploads/2023/04/Environmental.png)
Where a partnership is formed, TB Alliance funds their contributions to such a collaboration, and may also agree to fund certain activities to be performed by their partner in the collaboration or third parties in support of the collaboration.
![](https://niroglobal.com/wp-content/uploads/2023/04/Performance-Improvement.png)
For more information about partnership opportunities, please contact Gerald Siuta.